CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
January 2021—Bio-Rad Laboratories launched its SARS-CoV-2, Flu, RSV positive and negative run controls. The products enable laboratories to evaluate day-to-day and lot-to-lot variation of their multiplexed molecular assay and test for operator proficiency.
The SARS-CoV-2, Flu, RSV Positive Run Control is manufactured with whole organism SARS-CoV-2, influenza A, influenza B, and RSV subtype A. It is formulated in a synthetic matrix and contains human genomic DNA. The SARS-CoV-2, Flu, RSV Negative Run Control is negative for SARS-CoV-2, influenza A, influenza B, and RSV subtype A and is formulated in a synthetic matrix and contains human genomic DNA. The products are part of Exact Diagnostics’ range of QC products and are available in kits of five vials, have a 1.0-mL fill volume, and can be stored at -20°C or below.